Shares of Pfizer (NYSE:PFE) traded at a new 52-week high today of $36.46. So far today approximately 21.4 million shares have been exchanged, as compared to an average 30-day volume of 23.2 million shares.
In the past 52 weeks, Pfizer share prices have been bracketed by a low of $27.51 and a high of $36.46 and are now at $36.38, 32% above that low price. Over the last five market days, the 200-day moving average (MA) has gone up 0.4% while the 50-day MA has advanced 0.3%.
Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
Potential upside of 6.0% exists for Pfizer, based on a current level of $36.38 and analysts' average consensus price target of $38.56. The stock should find initial support at its 50-day moving average (MA) of $34.36 and further support at its 200-day MA of $33.04.